Vitamin D and its analogs as anticancer and anti-inflammatory agents

被引:60
作者
Chen, Jingxuan [1 ]
Tang, Ziyu [1 ]
Slominski, Andrzej T. [2 ]
Li, Wei [3 ]
Zmijewski, Michal A. [4 ]
Liu, Yao [5 ]
Chen, Jianjun [1 ]
机构
[1] Southern Med Univ, Sch Pharmaceut Sci, Guangdong Prov Key Lab New Drug Screening, Guangzhou 510515, Peoples R China
[2] Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL 35294 USA
[3] Univ Tennessee, Hlth Sci Ctr, Dept Pharmaceut Sci, Memphis, TN 38163 USA
[4] Med Univ Gdansk, Dept Histol, 1a Debinki, PL-80211 Gdansk, Poland
[5] Shanghai Jiao Tong Univ, Instrumental Anal Ctr, 800 Dongchuan Rd, Shanghai 200240, Peoples R China
关键词
Vitamin D analogs; Vitamin D receptor; Anticancer; Anti-inflammatory; 1-ALPHA; 25-DIHYDROXYVITAMIN D-3 ANALOGS; BREAST-CANCER CELLS; D-RECEPTOR LIGANDS; PROSTATE-CANCER; BIOLOGICAL EVALUATION; SIDE-CHAIN; NUCLEAR RECEPTOR; GENE-EXPRESSION; HEMODIALYSIS-PATIENTS; PANCREATIC-CANCER;
D O I
10.1016/j.ejmech.2020.112738
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Vitamin D3 is the precursor of the steroid hormone calcitriol (1 alpha,25-dihydroxyvitamin D3), a potent agonist of the transcription factor vitamin D receptor (VDR). Calcitriol has received large appreciation due to the impact not only on mineral homeostasis, but also on metabolic diseases, immunological disorders, and cancer. A supraphysiological dose of calcitriol is required to reduce the proliferation of cancer cells. However, the dose will lead to calcemic side effects such as hypercalcemia and hypercalciuria. Although several analogs of 1 alpha,25(OH)2D3 have shown potent anticancer or anti-inflammatory activity on cell cultures or in animal models, few vitamin D analogs have been successfully applied in the treatment of cancer or inflammatory diseases. This review will present and discuss vitamin D analogs that have the potential to be used as anticancer or anti-inflammatory agents. (C) 2020 Elsevier Masson SAS. All rights reserved.
引用
收藏
页数:17
相关论文
共 131 条
[1]   The role of vitamin D supplementation in patients with rheumatic diseases [J].
Abrahamsen, Bo ;
Harvey, Nicholas C. .
NATURE REVIEWS RHEUMATOLOGY, 2013, 9 (07) :411-422
[2]   Tacalcitol: A useful adjunct to narrow band ultraviolet B phototherapy in psoriasis [J].
Aggarwal, Parul ;
Aggarwal, Kamal ;
Jain, V. K. .
JOURNAL OF DERMATOLOGICAL TREATMENT, 2016, 27 (06) :546-551
[3]   Serum vitamin D receptor (VDR) levels as a potential diagnostic marker for colorectal cancer [J].
Al-Ghafari, Ayat B. ;
Balamash, Khadijah S. ;
Al Doghaither, Huda A. .
SAUDI JOURNAL OF BIOLOGICAL SCIENCES, 2020, 27 (03) :827-832
[4]  
Anna P., 2016, INT J MOL SCI, V17, P76
[5]   Ancient Nuclear Receptor VDR With New Functions: Microbiome and Inflammation [J].
Bakke, Danika ;
Sun, Jun .
INFLAMMATORY BOWEL DISEASES, 2018, 24 (06) :1149-1154
[6]   1α, 25-dihydroxyvitamin D3 suppresses interleukin-8-mediated prostate cancer cell angiogenesis [J].
Bao, Bo-Ying ;
Yao, Jorge ;
Lee, Yi-Fen .
CARCINOGENESIS, 2006, 27 (09) :1883-1893
[7]   The endocrine vitamin D system in the gut [J].
Barbachano, Antonio ;
Fernandez-Barral, Asuncion ;
Ferrer-Mayorga, Gemma ;
Costales-Carrera, Alba ;
Jesus Larriba, Maria ;
Munoz, Alberto .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2017, 453 (0C) :79-87
[8]   Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: A report from the ASCENT investigators [J].
Beer, Tomasz M. ;
Ryan, Christopher W. ;
Venner, Peter M. ;
Petrylak, Daniel P. ;
Chatta, Gurkamal S. ;
Ruether, J. Dean ;
Redfern, Charles H. ;
Fehrenbacher, Louis ;
Saleh, Mansoor N. ;
Waterhouse, David M. ;
Carducci, Michael A. ;
Vicario, Daniel ;
Dreicer, Robert ;
Higano, Celestia S. ;
Ahmann, Frederick R. ;
Chi, Kim N. ;
Henner, W. David ;
Arroyo, Alan ;
Clow, Fong W. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (06) :669-674
[9]   SPECIFIC HIGH-AFFINITY RECEPTORS FOR 1,25-DIHYDROXYVITAMIN-D3 IN HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS - PRESENCE IN MONOCYTES AND INDUCTION IN LYMPHOCYTES-T FOLLOWING ACTIVATION [J].
BHALLA, AK ;
AMENTO, EP ;
CLEMENS, TL ;
HOLICK, MF ;
KRANE, SM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1983, 57 (06) :1308-1310
[10]   Evidence-based complementary treatment of pancreatic cancer: a review of adjunct therapies including paricalcitol, hydroxychloroquine, intravenous vitamin C, statins, metformin, curcumin, and aspirin [J].
Bigelsen, Stephen .
CANCER MANAGEMENT AND RESEARCH, 2018, 10 :2003-2018